Skip to content
ppharmaranks
Menu
Class IIOngoing

Amantadine HCl recall

FDA recall D-0341-2026 · initiated Feb 13, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 4, 2026How we research

AvKARE recalled Amantadine HCl in Feb 2026 — an FDA Class II recall (D-0341-2026) because Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 49261, Exp: 04/30/27

Quantity recalled: N/A

Details

Product
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15.
Recalling company
AvKARE
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA.
Initiated
Feb 13, 2026
FDA report date
Mar 4, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Amantadine HCl recalled?
AvKARE recalled Amantadine HCl in Feb 2026 — an FDA Class II recall (D-0341-2026) because Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Amantadine HCl recalled?
Per the FDA enforcement record, the reason for recall D-0341-2026 was: Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
Is a recalled Amantadine HCl dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Amantadine HCl are affected?
Distributed: Nationwide in the USA.. The recall covers these lots — Lot # 49261, Exp: 04/30/27. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0341-2026.

Source: openFDA Drug Enforcement record D-0341-2026

← All drug recalls